who controlled by US and China.. thats why sputnik will never be approved.. even already news of mmp died from pier, moderna, jnj, and china vaccine.. but we never heard of pople died from Sputnik V.. ..but malaysia will never ever approved, hidung cucuk tali by western
PeeM visits Klang Hospital, promises help on the way..ASAP (we know what that stands for).....patients sleeps on the porch....He will send 151 beds and ONLY 15 Ventilators. 15 for who er? Where are the Billions for Healthcare? 15 Ventilators???.. Nice one.
SLOVAKIA member of EU has granted emergency use authorization EUA to SPUTNIK V...new COVID-19 VIRUS and DELTA VARIANT VIRUS daily cases dropped to 7...awesome...
UN SECRETARY-GENERAL ANTONIO GUTERRES said that the process of recognition by the WHO of SPUTNIK V was underway, and the UN would welcome its completion...
The First major skill to be a successful Politician.....ability to LIE with eyes wide open...No. 2, be the best Balls licker...No. 3, agility for U-Turns...etc, etc...
When the 1st Team failed,..set up a 2nd team...then a 3rd Task force..maybe a team to support the 3rd team...and all these people are from the same pool and group of people, only different names for the Teams.....Love it!
The very spot or exact venue to combat the Covid, ironically is the place where clusters are built on, ...results? breaching the 10K marks with such professional failure ease.
choose a good company...look at it after 2 years...take out some for 2 years spending...come back again after 2 years...LONG TERM sure good ...retire at 39...awesome...SPUTNIK V...
Oh, you're so right...this one was caught in March 2020 at 1.55 Probably the balance stock still in CDS for Bonus play. How about that? But Bonus 4 : 1 at Pharma...was a disaster. Investors left at penthouse 7.25! Pre Bonus at 5.25, presently at 4.60..ouch! So, Dpharma is different play?
Sinovac and other Chinese vaccines have a lot of adverse reports. So far, only Pfizer and Sputnik V able to withstand the Delta variant based on informations gathered worldwide.
Radio Nacional: "The effectiveness of Sputnik V against the Delta variant exceeds 90%"- Ana María Franchi, president of Argentina's National Scientific and Technical Research Council
Sputnik V uses two different human vectors (Ad26 & Ad5), making it the world’s first ‘vaccine cocktail’ against COVID-19 and contributing to its longer lasting immunity and high efficacy vs new coronavirus mutations.
NPRA to include approval for SINOPHARM vaccine tomorrow.....after less than a month's long review. Check out the important part..WHO approved.............
>>>> “Tomorrow the NPRA will meet and we will consider the Sinopharm vaccine, which was approved by the World Health Organisation.
“Their company just sent their dossiers to us, and in less than a month we have evaluated and will give our decision on the conditional approval tomorrow,” he said.
Kesabaran dan ketabahan Warga Dpharma yang menunggu sejak kunjungan Menteri Vaksin YB Khairy Jamaluddin pasti di balas dengan keuntungan berlebihan . Harap harap ia.
Kenyataan Akhbar KPK 16 Julai 2021 – Keputusan Mesyuarat Pihak Berkuasa Kawalan Dadah Kali Ke-361 Berkenaan Pendaftaran Vaksin COVID-19
Kementerian Kesihatan Kesihatan (KKM) ingin memaklumkan bahawa Mesyuarat Pihak Berkuasa Kawalan Dadah (PBKD) kali ke-361 telah bersidang pada hari ini, 16 Julai 2021. Mesyuarat telah bersetuju memberikan kelulusan pendaftaran bersyarat untuk kegunaan semasa bencana bagi dua (2) produk vaksin COVID-19 iaitu:
1. COVILO Suspension for Injection COVID-19 Vaccine (Vero Cell), Inactivated Pemegang pendaftaran: Duopharma (M) Sdn. Bhd. Pengilang: Beijing Institute of Biological Products Co. Ltd. (BIBP), China COVILO merupakan vaksin yang dibangunkan oleh China National Biotec Group Company Limited (CNBG), Sinopharm, yang juga dikenali sebagai vaksin COVID-19 Sinopharm.
2. Janssen COVID-19 Vaccine Suspension for Injection Pemegang pendaftaran: Johnson & Johnson Sdn. Bhd. Pengilang: Janssen Pharmaceutica N.V., Belgium
Kelulusan pendaftaran bersyarat ini memerlukan maklumat kualiti, keselamatan dan keberkesanan produk vaksin tersebut dipantau dan dinilai berdasarkan data-data terkini dari semasa ke semasa. Ia bagi memastikan perbandingan manfaat-risiko (benefit over risk) bagi produk-produk vaksin tersebut kekal positif.
KKM akan sentiasa mempertingkatkan tahap kesihatan awam dalam memerangi wabak COVID-19 melalui perolehan bekalan vaksin yang telah dinilai daripada aspek kualiti, keselamatan dan keberkesanan oleh Bahagian Regulatori Farmasi Negara (NPRA) dan diluluskan oleh PBKD. Kerajaan juga komited untuk memastikan penduduk dewasa Malaysia mencapai imuniti kelompok (herd immunity) selaras dengan sasaran Program Imunisasi COVID-19 Kebangsaan (PICK).
TAN SRI DATO’ SERI DR. NOOR HISHAM BIN ABDULLAH Ketua Pengarah Kesihatan Malaysia 16 Julai 2021
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Trevor777
3,055 posts
Posted by Trevor777 > 2021-07-13 11:31 | Report Abuse
No matter how it drops, will still close at 2.90